Ancora Heart is a leading medical device company that specializes in developing innovative solutions for the millions of people suffering from the debilitating effects of heart failure. As one of the leading causes of death today, heart failure requires effective treatment options. Ancora Heart has introduced AccuCinch®, the first percutaneous ventricular restoration system designed specifically for heart failure patients.

The AccuCinch Ventricular Restoration System has been granted Breakthrough Device Designation by the FDA, highlighting its potential in revolutionizing heart failure treatment. If you are experiencing common signs and symptoms of heart failure such as extreme fatigue, difficulty breathing, or memory loss, and have exhausted other treatments, the AccuCinch System may offer new possibilities for a better quality of life. The AccuCinch System has shown promise in early feasibility clinical data, improving quality of life, functional capacity, and initiating reverse remodeling in patients with heart failure.

Ancora Heart is currently conducting the CORCINCH-HF Study, a randomized, controlled clinical trial, to further evaluate the benefits of the AccuCinch System. With a dedicated team and a focus on innovation, Ancora Heart is committed to helping heart failure patients live more comfortably. Contact Ancora Heart today to learn more about their groundbreaking solutions